Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022

David Amsellem Initiated (AXSM) at Hold and Held Target at $75 on, Jan 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-75-on-jan-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Amsellem of Piper Sandler, Initiated "Axsome Therapeutics, Inc." (AXSM) at Hold and Held Target at $75 on, Jan 5th, 2023.

David has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $86 on, Tuesday, November 29th, 2022


These are the ratings of the 6 analyists that currently disagree with David


  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $80 on, Friday, November 11th, 2022
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, November 9th, 2022
  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022

Publication Contributing Sources